U.S. CRISPR & Cas Genes Market Insights Across Applications and Technologies
The U.S. CRISPR & Cas genes market, valued at USD 1.54 billion in 2024, is projected to reach USD 8.29 billion by 2034, growing at a CAGR of 18.4%. The rapid expansion is being propelled by advancements in gene therapy, genome editing, agriculture biotechnology, and synthetic biology, which are revolutionizing healthcare and industrial biotechnology. The U.S....
0 Comments 0 Shares 14 Views 0 Reviews
Abistem https://abistem.com